Anti-Histone H3 抗体 - Nuclear Loading Control (HRP) (ab21054)

ab21054 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab21054 は 9 報の論文で使用されています。

  • Battaglia S  et al. RNA-dependent chromatin association of transcription elongation factors and Pol II CTD kinases. Elife 6:N/A (2017). PubMed: 28537551
  • Shirai A  et al. Impact of nucleic acid and methylated H3K9 binding activities of Suv39h1 on its heterochromatin assembly. Elife 6:N/A (2017). PubMed: 28760201
  • Ma L  et al. Tankyrase inhibitors attenuate WNT/ß-catenin signaling and inhibit growth of hepatocellular carcinoma cells. Oncotarget 6:25390-401 (2015). WB . PubMed: 26246473
  • Nishibuchi G  et al. N-terminal phosphorylation of HP1a increases its nucleosome-binding specificity. Nucleic Acids Res 42:12498-511 (2014). PubMed: 25332400
  • Wei W  et al. Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin. Mol Cancer 10:16 (2011). WB ; Human . PubMed: 21314951
  • Hiragami-Hamada K  et al. N-terminal phosphorylation of HP1{alpha} promotes its chromatin binding. Mol Cell Biol 31:1186-200 (2011). PubMed: 21245376
  • Vizoso Vázquez A  et al. Two proteins with different functions are derived from the KlHEM13 gene. Eukaryot Cell 10:1331-9 (2011). WB ; Human . PubMed: 21821717
  • Binda O  et al. Trimethylation of histone H3 lysine 4 impairs methylation of histone H3 lysine 9: regulation of lysine methyltransferases by physical interaction with their substrates. Epigenetics 5:767-75 (2010). PubMed: 21124070
  • Wei W  et al. Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. Mol Cancer 8:76 (2009). WB ; Human . PubMed: 19778454

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録